Aterian (ATER) to Release Quarterly Earnings on Thursday

Aterian (NASDAQ:ATER) is projected to release its Q1 2026 results before the market opens on Thursday, May 14th. Analysts expect Aterian to post earnings of ($0.69) per share and revenue of $15.82 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Wednesday, May 20, 2026 at 5:00 PM ET.

Aterian Price Performance

NASDAQ ATER opened at $1.12 on Tuesday. Aterian has a 1-year low of $0.52 and a 1-year high of $2.19. The stock has a 50-day moving average of $0.71 and a two-hundred day moving average of $0.74. The company has a market cap of $12.12 million, a P/E ratio of -0.47 and a beta of 0.66.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. lifted its position in Aterian by 73.0% during the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock worth $45,000 after buying an additional 9,026 shares during the period. XTX Topco Ltd acquired a new stake in shares of Aterian during the 2nd quarter worth $55,000. Citadel Advisors LLC grew its position in Aterian by 222.0% during the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock valued at $35,000 after acquiring an additional 22,865 shares during the period. Finally, Susquehanna International Group LLP raised its holdings in shares of Aterian by 310.2% in the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock worth $43,000 after purchasing an additional 30,637 shares during the period. 7.02% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Aterian in a research report on Monday, April 20th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Aterian currently has a consensus rating of “Sell”.

Aterian Company Profile

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.